|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 241.38 USD | +0.90% |
|
+5.87% | +13.20% |
| Capitalization | 12.74B 14.82B 11.56B 11.09B 20.25B 1,366B 20.98B 136B 54.38B 651B 55.61B 54.42B 2,326B | P/E ratio 2026 * |
45.2x | P/E ratio 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise value | 12.16B 14.14B 11.03B 10.58B 19.32B 1,303B 20.02B 130B 51.89B 622B 53.07B 51.92B 2,220B | EV / Sales 2026 * |
8.68x | EV / Sales 2027 * | 5.77x |
| Free-Float |
97.58% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ascendis Pharma A/S
| 1 day | +0.90% | ||
| 1 week | +5.87% | ||
| Current month | +3.37% | ||
| 1 month | +9.85% | ||
| 3 months | +15.73% | ||
| 6 months | +21.83% | ||
| Current year | +13.20% |
| 1 week | 224.21 |  | 248.6 |
| 1 month | 211 | | 248.6 |
| Current year | 188.08 | | 248.6 |
| 1 year | 124.06 | | 248.6 |
| 3 years | 64.33 | | 248.6 |
| 5 years | 61.58 | | 248.6 |
| 10 years | 11.92 | | 248.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jan Mikkelsen
CEO | Chief Executive Officer | 67 | 01/12/2007 |
Scott Smith
DFI | Director of Finance/CFO | 53 | 08/08/2016 |
Aimee Shu
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/07/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Mikkelsen
BRD | Director/Board Member | 67 | 01/12/2007 |
Albert Cha
CHM | Chairman | 54 | 28/05/2021 |
Lisa Bright
BRD | Director/Board Member | 59 | 01/04/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.90% | +5.87% | +60.06% | +111.51% | 14.82B | |
| -0.82% | -1.95% | -9.85% | -7.52% | 47.3B | |
| -12.27% | -19.26% | +11.88% | +43.13% | 29.54B | |
| +0.67% | -15.11% | +16.21% | +23.91% | 33.17B | |
| +2.25% | +9.86% | -3.10% | -19.45% | 29.86B | |
| +0.70% | -1.99% | +166.57% | +297.60% | 20.05B | |
| -1.08% | -2.30% | +30.49% | +6.54% | 13.72B | |
| +0.10% | +6.34% | +43.61% | +133.17% | 13.22B | |
| +1.00% | -1.83% | +141.12% | +117.08% | 13.12B | |
| +6.09% | -4.00% | +23,036.36% | +3,586.80% | 12.58B | |
| Average | -0.25% | -2.60% | +2,349.34% | +429.28% | 22.74B | |
| Weighted average by Cap. | -0.93% | -3.56% | +1,307.49% | +251.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.4B 1.63B 1.27B 1.22B 2.23B 150B 2.31B 14.93B 5.98B 71.6B 6.11B 5.98B 256B | 1.99B 2.32B 1.81B 1.74B 3.17B 214B 3.28B 21.26B 8.51B 102B 8.71B 8.52B 364B |
| Net income | 286M 332M 259M 249M 454M 30.62B 470M 3.04B 1.22B 14.6B 1.25B 1.22B 52.15B | 695M 808M 630M 605M 1.1B 74.47B 1.14B 7.4B 2.96B 35.51B 3.03B 2.97B 127B |
| Net Debt | -584M -679M -530M -508M -928M -62.6B -962M -6.23B -2.49B -29.86B -2.55B -2.49B -107B | -1.23B -1.43B -1.12B -1.07B -1.96B -132B -2.03B -13.14B -5.26B -63.02B -5.38B -5.26B -225B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/03/26 | 241.38 $ | +0.90% | 782,392 |
| 03/03/26 | 239.22 $ | -1.19% | 1,051,167 |
| 02/03/26 | 242.09 $ | +3.68% | 1,418,735 |
| 27/02/26 | 233.50 $ | +1.97% | 775,325 |
| 26/02/26 | 228.99 $ | +0.43% | 595,933 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ASND Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition